RT Conference Proceedings
T1 Identification Of Novel Disease Biomarkers In Systemic Sclerosis Through High-Throughput Proteomics
A1 Castro, R. Ortega
A1 Pilar, F. U.
A1 Martinez-Monllor, M.
A1 Munoz-Barrera, L.
A1 Sanchez-Pareja, I.
A1 Abalos-Aguilera, M. C.
A1 Puerto, N. Barbarroja
A1 Estevez, E. Collantes
A1 Aguirre-Zamorano, M. A.
A1 Perez-Sanchez, C.
A1 Lopez-Pedrera, C.
K1 Scleroderma, systemic
K1 Fibrosis
K1 Autoimmune diseases
AB Background: Systemic sclerosis (SSc) is an autoimmune disease characterizedby vasculopathy, tissue fibrosis and activation of the innate and adaptive immune system. Clinical features of the disease consist of skin thickening and internal organ involvement. Due to the heterogeneous nature of the disease, there is an unmet need of biomarkers for diagnosis, disease progression and response to treatment.
PB BMJ Group
SN 0003-4967
YR 2022
FD 2022-06-01
LK http://hdl.handle.net/10668/20122
UL http://hdl.handle.net/10668/20122
LA en
NO Castro RO, Pilar FU, Martinez-Monllor M, Muñoz-Barrera L, Sanchez-Pareja I, Ábalos-Aguilera MC, et al. POS0488 IDENTIFICATION OF NOVEL DISEASE BIOMARKERS IN SYSTEMIC SCLEROSIS THROUGH HIGH-THROUGHPUT PROTEOMICS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):498.3-499
DS RISalud
RD Apr 8, 2025